ArticleIn reply: The PARADIGM-HF trialAuthor:Marwa A. Sabe, MD, MPHPublish date: March 1, 2016The findings of PARADIGM-HF have sparked much conversation and implementation of practice change in the treatment of heart failure.Read More
ArticleA new class of drugs for systolic heart failure: The PARADIGM-HF studyAuthor:Marwa A. Sabe, MD, MPHPublish date: October 1, 2015Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.Read More
